China Approaches Brain-Computer Interface Breakthrough: Key Takeaways From ZGC Forum 2026
At Beijing's ZGC Forum, developers showcased cutting-edge brain-computer interface products including Beinao-1 and Beinao-2 systems. Experts predict mass BCI adoption in China within 3–5 years.
ZGC Forum Reveals the Scale of China's BCI Ambitions
From March 25 to 29, Beijing hosted the ZGC Forum, where developers unveiled an extensive range of brain-computer interface (BCI) products — from specialized microchips to full rehabilitation systems. The exhibits drew significant attention from attendees, according to China.org.
Zhao Jizong, a neurosurgery expert and academician at the Chinese Academy of Sciences, highlighted the rapid pace of technological advancement and the expanding scope of BCI applications.
Beinao-1 and Beinao-2: Flagship Developments
Two products garnered particular attention — Beinao-1 and Beinao-2:
- Beinao-1 is a semi-invasive system already implanted in seven patients. All have recovered successfully and partially regained motor and speech functions.
- Beinao-2 is an invasive implant featuring flexible electrodes designed for full brain integration. It is currently undergoing extensive animal trials and is expected to advance to clinical testing in 2026.
The developer of Beinao-2, NeuCyber Neurotech, acknowledged that its product trails Neuralink's technology by approximately three years. Elon Musk's company holds an advantage with its surgical robot, capable of inserting hundreds of electrodes into the brain within minutes for the N1 chip.
Why This Matters
BCI technology establishes a direct communication channel between the brain and external devices, enabling patients to control machines through interpreted neural signals. The need is particularly acute in China: according to Zhao Jizong, the country has more than 3.7 million patients suffering from neurological conditions. BCI represents a fundamentally new avenue for rehabilitation.
The Chinese government has designated BCI as a priority industry of the future and enacted supportive policies for research and deployment. Medical institutions across Beijing, Tianjin, Guangzhou, Wuhan, Nanjing, and other cities have already established dedicated BCI clinics and research departments. Domestically developed solutions are being applied in disease diagnostics, motor function recovery, and neuromodulation.
Acceleration Since 2025 and Roadmap to 2030
Gu Xiaosong, an academician at the Chinese Academy of Engineering, noted that BCI development in China has accelerated significantly since 2025, with many technologies reaching the applied verification stage and producing impressive results.
Regional infrastructure is also taking shape. Lin Han, deputy head of Beijing's Haidian district, reported that 27 BCI companies currently operate in the area. By 2030, the district aims to attract around 100 innovative small and medium enterprises and achieve mass deployment of BCI products across healthcare, rehabilitation, industry, and education.
Real-World BCI Applications Within 3–5 Years
Yao Dezhong, director of the Sichuan Institute of Neuroscience, stated that practical BCI applications in China will begin within three to five years. He pointed to several key advantages: a massive population, strong patient demand, efficient industrial capacity, and a deep talent pool.
Yao also highlighted plans to integrate BCI into insurance frameworks and develop national standards, aiming to close what he described as a significant gap between laboratory research and clinical practice.
Different Approaches: China vs. Neuralink
While American startups like Neuralink focus primarily on invasive chips that penetrate brain tissue, Chinese researchers are simultaneously developing surface-implantable and non-invasive solutions with broader clinical potential. This approach may sacrifice some signal quality but significantly reduces risks of tissue damage and post-surgical complications.
Forum experts acknowledged persistent challenges, including technology reliability, safety concerns, and unresolved ethical questions.
Earlier in March, China's regulator approved the country's first neuroimplant for commercial use.
Frequently Asked Questions
What are Beinao-1 and Beinao-2 brain implants?
Beinao-1 is a semi-invasive BCI system already implanted in seven patients who partially regained motor and speech functions. Beinao-2 is an invasive implant with flexible electrodes currently in animal testing, expected to begin clinical trials in 2026.
How far behind Neuralink is China in BCI technology?
NeuCyber Neurotech, the developer of Beinao-2, estimates its product is approximately three years behind Neuralink's technology. Neuralink's key advantage is a surgical robot that can insert hundreds of electrodes in minutes.
When will BCI be commercially available in China?
Yao Dezhong, director of the Sichuan Institute of Neuroscience, stated that practical BCI applications in China will begin within three to five years. By 2030, Beijing's Haidian district alone plans to attract around 100 innovative BCI companies.
How many BCI companies operate in China?
According to Lin Han, deputy head of Beijing's Haidian district, 27 BCI companies currently operate in that region alone. The district plans to grow this number to approximately 100 innovative small and medium enterprises by 2030.
How does China's BCI approach differ from Neuralink's?
While Neuralink focuses on invasive chips that penetrate brain tissue, Chinese researchers are also developing surface-implantable and non-invasive solutions. This approach may reduce signal quality but lowers risks of tissue damage and post-surgical complications.
Read also
Science Corporation Prepares Human Trials for Biohybrid Brain-Computer Chip
Science Corporation, founded by former Neuralink president Max Hodak, has recruited a Yale neurosurgeon to prepare first-in-human trials of a biohybrid brain-computer interface that merges lab-grown neurons with electronics.
Australia Launches Trials of Synchron's Brain Implant for Smartphone Control via Thought
Clinical trials of Synchron's upgraded Stentrode brain-computer interface have begun in Melbourne, enabling ALS patients to control smartphones using only their thoughts.
Paralyzed Musician Creates Music Using Brain-Computer Interface
Galen Buckwalter, a brain-computer interface user, has learned to generate music through neural signals and already incorporated the results into a track by his punk rock band.
Chinese Scientists Develop Neuro-Helmet for Mind-Controlled Robot Dog
Researchers at Xi'an Jiaotong University have built a non-invasive brain-computer interface that lets users control a robot dog with their thoughts, achieving over 95% command recognition accuracy.
Brain Implant Lets Paralyzed Man Type 80% Faster Than Average
A brain-computer interface decoding imagined finger movements enabled a paralyzed ALS patient to type at 110 characters per minute — 80% faster than the average healthy person.
US DOJ Seizes Over $580M in Crypto Linked to Chinese Criminal Organizations
The U.S. Department of Justice seized more than $580 million in cryptocurrency tied to Chinese criminal organizations, marking one of the largest crypto enforcement actions in history.